191 related articles for article (PubMed ID: 6463893)
21. The relations between the antinuclear, rheumatoid and L.E.-cell factors in the systemic rheumatic diseases.
HALL AP; BARDAWIL WA; BAYLES TB; MEDNIS AD; GALINS N
N Engl J Med; 1960 Oct; 263():769-75. PubMed ID: 13710745
[No Abstract] [Full Text] [Related]
22. Treatment of disseminated lupus erythematosus and rheumatoid arthritis with methylprednisolone.
McMAHON FG; GORDON ES
J La State Med Soc; 1959 Jun; 111(6):201-10. PubMed ID: 13665203
[No Abstract] [Full Text] [Related]
23. [The level of the tumor necrosis factor in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis].
Prokop'ev AA; Alekseeva TG; Zimina ZV; Ketlinskiĭ SA
Ter Arkh; 1993; 65(5):9-12. PubMed ID: 8036608
[TBL] [Abstract][Full Text] [Related]
24. CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis.
Vogt B; Führnrohr B; Müller R; Sheriff A
Autoimmunity; 2007 Jun; 40(4):295-8. PubMed ID: 17516213
[TBL] [Abstract][Full Text] [Related]
25. [Importance and mechanism of P-phenomenon].
Mairose UB; Wolf E; Tolk J; Földi K
Z Rheumaforsch; 1971; 30(1):34-9. PubMed ID: 5123098
[No Abstract] [Full Text] [Related]
26. [Immunoregulatory subpopulations of T-lymphocytes of systemic lupus erythematosus patients before and after hemosorption].
Lysenko GI; Gandzha IM; Mel'nikov OF; Sambur MB
Vrach Delo; 1987 Feb; (2):94-8. PubMed ID: 2883772
[No Abstract] [Full Text] [Related]
27. Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis.
Gabay C; Roux-Lombard P; de Moerloose P; Dayer JM; Vischer T; Guerne PA
J Rheumatol; 1993 May; 20(5):815-21. PubMed ID: 8336307
[TBL] [Abstract][Full Text] [Related]
28. C-reactive protein and systemic lupus erythematosus.
Gaitonde S; Samols D; Kushner I
Arthritis Rheum; 2008 Dec; 59(12):1814-20. PubMed ID: 19035410
[No Abstract] [Full Text] [Related]
29. [The content of interleukin-1 beta in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis].
Ketlinskiĭ SA; Alekseeva TG; Perumov ND; Simbirtsev AS
Ter Arkh; 1993; 65(12):51-4. PubMed ID: 8146772
[TBL] [Abstract][Full Text] [Related]
30. [Experience with au-bi-ol, combined preparation of gold and bismuth, valuable remedy against rheumatoid arthritis and lupus erythematosus even in general practice].
SCHERSTEN B
Sven Lakartidn; 1954 Sep; 51(39):2419-33. PubMed ID: 13205490
[No Abstract] [Full Text] [Related]
31. [Plasma exchange in rheumatoid arthritis and systemic lupus erythematosus using the new Y-S sac system].
Shiokawa J
Ter Arkh; 1982; 54(6):49-54. PubMed ID: 7112419
[No Abstract] [Full Text] [Related]
32. [Effects of hemosorption on the regulation of calcium metabolism in patients with rheumatoid arthritis].
Trusov VV; Bazhenov AN
Klin Med (Mosk); 1992 Feb; 70(2):54-7. PubMed ID: 1507823
[TBL] [Abstract][Full Text] [Related]
33. [Use of magnetosorbents in the immunodiagnosis and therapy of systemic lupus erythematosus and rheumatoid arthritis].
Zborovskiĭ AB; Gontar' IP
Klin Med (Mosk); 2001; 79(2):42-5. PubMed ID: 11419085
[TBL] [Abstract][Full Text] [Related]
34. Serum amyloid P-component levels in rheumatoid arthritis.
Levo Y; Ehrenfeld M; Wollner S
Isr J Med Sci; 1982 Jun; 18(6):715-7. PubMed ID: 7107210
[No Abstract] [Full Text] [Related]
35. [The effect of hemosorption and plasmapheresis on fibrinogen-125I kinetics in patients with rheumatoid arthritis].
Bazhanov AN; Golubeva LV; Trusov VV
Ter Arkh; 1995; 67(6):50-2. PubMed ID: 7667782
[TBL] [Abstract][Full Text] [Related]
36. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
37. [Behavior of the rheumatoid factor under long-term penicillamine therapy in primary chronic polyarthritis and lupus erythematosus disseminatus].
Prohaska E
Wien Z Inn Med; 1966 May; 47(5):196-202. PubMed ID: 6005164
[No Abstract] [Full Text] [Related]
38. A functional Ser(413)/Ser(413) PAI-2 polymorphism is associated with susceptibility and damage index score in systemic lupus erythematosus.
Palafox-Sánchez CA; Vázquez-Del Mercado M; Orozco-Barocio G; García-De la Torre I; Torres-Carrillo N; Torres-Carrillo NM; Illades-Aguiar B; Muñoz-Valle JF
Clin Appl Thromb Hemost; 2009; 15(2):233-8. PubMed ID: 18818228
[TBL] [Abstract][Full Text] [Related]
39. Serum cortisol reduction and abnormal prolactin and CD4+/CD8+ T-cell response as a result of controlled exercise in patients with rheumatoid arthritis and systemic lupus erythematosus despite unaltered muscle energetics.
Pool AJ; Whipp BJ; Skasick AJ; Alavi A; Bland JM; Axford JS
Rheumatology (Oxford); 2004 Jan; 43(1):43-8. PubMed ID: 12867581
[TBL] [Abstract][Full Text] [Related]
40. Lymphocytotoxins in rheumatoid arthritis.
Levo Y; Waisman Y; Ehrenfeld M
Isr J Med Sci; 1980 Nov; 16(11):791-4. PubMed ID: 6969241
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
